Market Tracker

07/30 8:53am ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.03
Data as of Jul 29
 +0.04 / +0.80%
Today’s Change
3.10
Today|||52-Week Range
7.45
-5.63%
Year-to-Date

Today’s Trading

Previous close4.99
Today’s open5.00
Day’s range4.96 - 5.10
Volume842,129
Average volume (3 months)1,425,434
Market cap$349.9M
Dividend yield--
Data as of 07/29/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+67.11%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratioNM
Price/Sales37.83
Price/Book3.87

Competitors

 Today’s
change
Today’s
% change
GALEGalena Biopharma Inc+0.04+1.37%
SGYPSynergy Pharmaceutic...+0.12+3.31%
PETXAratana Therapeutics...-0.09-0.73%
DRTXDurata Therapeutics ...-0.55-4.12%
Data as of 07/29/2014

Financials

Next reporting dateAugust 7, 2014
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts